To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

July 23, 2018

Today's Rundown

Featured Story

Human Longevity accuses J. Craig Venter of stealing secrets

Human Longevity has accused its co-founder and former CEO, J. Craig Venter, of sharing secrets with competitors. The company made the accusations in a filing to sue the J. Craig Venter Institute.

Top Stories

Sangamo strikes TxCell takeover to gain CAR-Treg pipeline

Sangamo Therapeutics is set to acquire TxCell for its CAR-Treg platform and pipeline. The €72 million ($84 million) takeover will position Sangamo to move a CAR-carrying regulatory T cell candidate into testing in solid organ transplant patients next year.

Alzheon says data back plans for phase 3 program

Alzheon is still trying to build a case for a pivotal trial of its Alzheimer’s candidate, and the company says it has new data backing up the drug’s use in patients genetically predisposed to develop the disease.

[Sponsored] Q&A with Cardinal Health Regulatory Sciences: Navigating cell and gene therapies through clinical and regulatory hurdles

Gene and cell therapies are at the cutting-edge of biomedical research, promising potentially curative options for a host of disorders such as forms of blindness, blood cancers and inherited diseases.

Epizyme poaches SQZ Biotech, Tesaro biotech veteran Shefali Agarwal as CMO

Epizyme, in the midst of a partial clinical hold on a test for its experimental drug tazemetostat, has hired a new chief medical officer.

Anima, Eli Lilly pen $1B-plus biobucks research pact

Little-known private biotech Anima Biotech has signed a deal with Eli Lilly potentially worth more than $1 billion in biobucks as the pair seek to work on the biotech’s translation inhibitors.

Sanofi VC arm backs $17M round for digital medicine startup Click Therapeutics

French Big Pharma Sanofi, through its venture arm, has led a $17 million funding round for Click Therapeutics, a startup looking to boost work on an online platform of “prescription digital therapeutics.”

Resources

[Whitepaper] Building the Business Case for RIM Transformation

Ready to modernize your RIM environment? Secure buy-in with these tips.

[Whitepaper] How early planning and a unified data platform can cut trial timelines and cost.

Accelerate Clinical Research as Study Complexity Grows

[Whitepaper] Rise in Targeted Therapies Drives Needs for Small Volume Manufacturing

Biologics, orphan drugs, and precision medicine are on the rise, and that means some big changes for drug development and manufacturing companies. What should pharma companies look for when navigating this new era of small-volume manufacturing? Here are some ideas to consider when developing a new manufacturing strategy.

[Whitepaper] eClinical Landscape Study - CRO Report from Tufts Center for the Study of Drug Development

See results from the Tufts eClinical Landscape Study – CRO Report on current data management practices, goals, and challenges for contract research organizations (CROs).

[Whitepaper] Digitizing the Global Life Sciences Supply Chain: The Critical Role of Digital Transaction Management

Life science companies are experiencing a significant transformation in how they bring new products to market.

Events

.